More than a decade after coining “Treat Yo’ Self Day” in her role as Donna on “Parks & Recreation,” Retta is once again ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Abbott rolled out its first over-the-counter glucose sensor in the U.S. on Thursday, just over one week after Dexcom began selling its competing product. The device, called Lingo, is intended to be ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

Thursday, Abbott Laboratories ABT said it is recalling some FreeStyle Libre 3 sensors after finding that ... There have been no reports of death. Also Read: Dexcom’s Stelo Device Brings ...

Ithaka US Growth Strategy highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the second quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company engages in the ...

It has 6 ratings, of which 5 are buy, 1 is hold and none are sell ... DexCom's management has been actively engaged in share buybacks, a sign that it is confident in the company's valuation and future ...

Stock indexes may have rallied higher since bottoming in August. But, some stocks have fallen behind, and are looking to ...

DexCom's management has been actively engaged in share buybacks, a sign that it is confident in the company's valuation and future prospects. Announced the U.S. launch of Stelo, a sensor aimed at ...